![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
JP Zacny, JL Lichtor, D Flemming, DW Coalson and WK Thompson
Department of Anesthesia and Critical Care, Pritzker School of Medicine, University of Chicago, Illinois.
The purpose of this study was to characterize the subjective, psychomotor and physiological effects of morphine in healthy volunteers. Subjects (10 males and 2 females) without histories of opiate dependence were injected in an antecubetal vein with 0, 2.5, 5.0 or 10 mg/70 kg of morphine, by using a randomized, double-blind, cross- over design. Subjective effects, psychomotor performance and physiological measures were assessed immediately before the injection and for up to 5 hr afterward. Morphine increased the Pentobarbital- Chlorpromazine-Alcohol Group, Amphetamine, the Lysergic Acid Diethylamide and the Morphine-Benzedrine Group scores and decreased Benzedrine Group scores on the Addiction Research Center Inventory. Increased visual analog scale ratings of "stimulated," "high," "sedated," "coasting or spaced out" and "drunken" were also obtained. On an opiate adjective checklist, subjects reported increased ratings of "flushing," "dry mouth" and "tingling." Drug liking was not significantly altered by morphine, but there was substantial intersubject variability with this measure. Some aspects of psychomotor performance (reaction time, Digit Symbol Substitution Test and Maddox Wing) were impaired by morphine; however, eye-hand coordination was not. Miosis was induced by morphine. Most effects of morphine were dose- related, some effects peaked soon after morphine injection (e.g., increased stimulated and high ratings) and dissipated gradually, whereas other effects did not peak until later into the session (sedation or exophoria). Our results are fairly consistent with other studies examining morphine effects in healthy volunteers, and also indicate that the profile of morphine effects differ between healthy volunteers and those with a history of opiate dependence.
This article has been cited by other articles:
|
|
 |
|
  C.-S. Yuan, H. Doshan, M. R. Charney, M. O'Connor, T. Karrison, S. A. Maleckar, R. J. Israel, and J. Moss Tolerability, Gut Effects, and Pharmacokinetics of Methylnaltrexone Following Repeated Intravenous Administration in Humans J. Clin. Pharmacol., May 1, 2005; 45(5): 538 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. McNamara Opioid switching from morphine to transdermal fentanyl for toxicity reduction in palliative care Palliative Medicine, July 1, 2002; 16(5): 425 - 434. [Abstract] [PDF]
|
|
|
|
 |
|
 C.-S. Yuan, G. Wei, J. F. Foss, M. O'Connor, T. Karrison, and J. Osinski Effects of Subcutaneous Methylnaltrexone on Morphine-Induced Peripherally Mediated Side Effects: A Double-Blind Randomized Placebo-Controlled Trial J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 118 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Marsch, W. K. Bickel, G. J. Badger, J. P. Rathmell, M. D. B. Swedberg, B. Jonzon, and C. Norsten-Hoog Effects of Infusion Rate of Intravenously Administered Morphine on Physiological, Psychomotor, and Self-Reported Measures in Humans J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 1056 - 1065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Walker and J. P. Zacny Subjective, Psychomotor, and Physiological Effects of Cumulative Doses of Opioid µ Agonists in Healthy Volunteers J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1454 - 1464. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. R. Perry and E. Warner Transient encephalopathy after Taxol infusion Neurology, October 1, 1997; 49(4): 1189 - 1189. [Full Text] [PDF]
|
|
|
|
|
|
R. Walz, M. M. Bianchin, and F. Kliemann Transient encephalopathy after Taxol infusion Neurology, October 1, 1997; 49(4): 1188 - 1189. [Full Text] [PDF]
|
|
|
|
|
|
J. P. Zacny, K. Conley, and J. Galinkin Comparing the Subjective, Psychomotor and Physiological Effects of Intravenous Buprenorphine and Morphine in Healthy Volunteers J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1187 - 1197. [Abstract] [Full Text]
|
|
|
|
|
|
J. P. Zacny, K. Conley, and S. Marks Comparing the Subjective, Psychomotor and Physiological Effects of Intravenous Nalbuphine and Morphine in Healthy Volunteers J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1159 - 1169. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. A. Marshall, B. Bolognese, J. D. Winkler, and A. Roshak Depletion of Human Monocyte 85-kDa Phospholipase A2 Does Not Alter Leukotriene Formation J. Biol. Chem., January 10, 1997; 272(2): 759 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Rabey, T. A. Treves, M. Y. Neufeld, E. Orlov, and A. D. Korczyn Low-dose Clozapine in the Treatment of Levodopa-Induced Mental Disturbances in Parkinson's Disease Neurology, March 1, 1995; 45(3): 432 - 434. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
